Prevalence of left ventricular hypertrophy in a hypertensive population

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Prevalence of left ventricular hypertrophy in a hypertensive population"

Transcription

1 European Heart Journal (1996) 17, Prevalence of left ventricular hypertrophy in a hypertensive population J. Tingleff, M. Munch, T. J. Jakobsen, C. Torp-Pedersen, M. E. Olsen, K. H. Jensen, T. Jorgensen and M. Kirchoff The Glostrup Population Studies, Department of Internal Medicine C, Glostrup County Hospital, University of Copenhagen, Denmark Aims This investigation was set up to study the prevalence of left ventricular hypertrophy in a hypertensive population with reference to a normotensive control group. From the general population 3498 men and women aged 35, 45, and years old were invited to a health examination. Participants with blood pressure above 160mmHg systolic or 95 mmhg diastolic or those taking antihypertensive medication or having done so during the previous 6 months were asked to undergo an echocardiographic examination. Normotensive controls were randomly selected from the same population. Of 2 participants in the final study population, 194 were normotensive controls and 358 were in the hypertensive group. Echocardiographic measurements were made according to the Penn conventions and indexed for body surface. Cut-off values for left ventricular hypertrophy were 134 g. m ~ 2 for males and 102 g. m ~ 2 for women. Introduction The presence of left ventricular hypertrophy in hypertensive patients, diagnosed by electrocardiographic criteria, is associated with a risk of mortality from cardiovascular disease three times greater than the risk associated with hypertension alone 1 ' 1. When echocardiographic criteria for left ventricular hypertrophy are used, the prevalence of hypertrophy is much higher than when electrocardiographic (ECG) criteria are used, both in the general population and in hypertensive patients 12 ' 3 '. Echocardiographic left ventricular hypertrophy is also associated with increased risk of cardiovascular disease and death in hypertensive men' 41 and in the general population' 51. The prevalence of left ventricular hypertrophy determined by echocardiography in hypertensive patients has been reported to be 23% to 48%' 6-8 ', but Revision submitted 7 February 1995, and accepted 7 March Correspondence: Jens Tingleff, MD, Department of Cardiothoracic Surgery, University Hospital of Copenhagen, Rigshospitalet, 9-Blegdamsvej, DK Copenhagen, Denmark. Results Overall, the prevalence of left ventricular hypertrophy was /20% (men/women) in normotensives and 25%/% in hypertensives (/ > <001). After subdivision by age and sex, there was a significant difference in the prevalence of left ventricular hypertrophy between normotensives and hypertensives only in the -year-old group (P<002 for males and P<005 for females). Conclusion The association between blood pressure and left ventricular hypertrophy in the general population is weak. Left ventricular hypertrophy is only significantly more frequent among hypertensives as compared to normotensives in older people. (Eur Heart J 1996; 17: ) Key Words:, left ventricular hypertrophy, prevalence, echocardiography, general population. comparisons between left ventricular hypertrophy in hypertensives and normal subjects are hampered by a possible biased selection of both hypertensive patients and normal controls. In the present study, a random sample of the population was screened for hypertension. The prevalence of left ventricular hypertrophy denned by echocardiographic criteria in those with hypertension was investigated and the results compared with a randomly selected normotensive group among the same population. Methods Study population In 1982, a random sample of 4807 men and women, bora in 1922, 1932, 1942 or 1952, and living in the western part of Copenhagen County, was drawn from the Civil Registration System. Two hundred and twenty six subjects of foreign origin were excluded, reducing the sample to Of these, 3608 persons attended a general health examination X/96/OI $12.00/ The European Society of Cardiology

2 1 J. Tingleffet al. By 1987, 110 subjects had died, leaving a total of 3498 who were asked to participate in a follow-up examination. This was attended by 2987 persons (85%). The remainder did not respond to our invitation or refused to be examined. Participants underwent a general health examination including measurement of blood pressure in the supine and sitting positions. Information on medical treatment of hypertension was obtained. All subjects in whom the blood pressure was above 160mmHg systolic and/or 95 mmhg diastolic and subjects who had received treatment for hypertension within the last 6 months were asked to undergo an echocardiographic examination. In subjects with normal blood pressure, but on antihypertensive medical treatment, records from the hospital/clinic which initiated the treatment were evaluated. As controls, a random subgroup of age- and gender-matched subjects were also asked to participate. Participants in this group were normotensive and had normal ECGs. For every two subjects with possible hypertension, one control was invited to participate. Of a total of 927 subjects asked to undergo an echocardiographic examination (609 suspected hypertensives, 318 controls), 6 accepted the invitation (72%) (438 suspected hypertensives, 227 controls). There was no difference between participants and non-participants as regards height, weight and blood pressure based on the data from the 1987 examination. Due to poor echocardiographic image quality, 113 participants (17%) were excluded. The final study population, therefore, consisted of 2 subjects (358 suspected hypertensives, 194 controls). Since the prevalence of hypertension in the age groups of 35 and 45 years was similar, the data from these two groups were pooled. Verbal informed consent was obtained from each participant before examination. The study protocol was approved by the ethics committee for Copenhagen County, and was in accordance with the Helsinki II declaration. Echocardiographic methods All studies were performed with a Toshiba model 60A echocardiograph equipped with a 3-4 MHz transducer. Standard M-mode echocardiography was performed at the tip of the mitral valve. M-mode examinations were guided by two-dimensional scan. Measurements were made according to the Penn conventions' 9 ' (mean value of three consecutive cardiac cycles) and was performed blind to other information on the participant. Left ventricular mass was calculated by the formula left ventricular mass=104 [(LVIDD + IVS + LVPW) 3 - (LVIDD) 3 ] g, where LVIDD denotes the diastolic left ventricular internal dimension (cm), IVS the diastolic interventricular septal thickness, and LVPW the diastolic left ventricular posterior wall. Because of the correlation between surface area and left ventricular mass observed in the normal population' 2101, all values reported here for left ventricular mass are mass per m 2 body surface area unless otherwise specified. Data from the Framingham study suggested cut-off values for left ventricular hypertrophy of 131 g.m" 2 for males and loog.rn" 2 for females' 71. Devereux et a/.'" 1, studying normal people at work and apparently normals attending a cardiology clinic, suggested cut-off values of g. m"~ 2 for males and g. m " 2 for females. Based on these studies, we chose cut-off values of 134 g. m ~ 2 for males and 102 g. m ~ 2 for females. To study the applicability of these results in our sample, we chose a 'super-normal' subpopulation, as was done in the Framingham study. We found 89 subjects with no known cardiac or pulmonary disease, no drug treatment, blood pressure below 140/90, and no over- or underweight (body mass index no deviating more than 20% of recommended). Blood pressure measurement All blood pressures were measured after at least 10 min in the sitting position. They were measured both at the general health examination by the auscultatory method with a Hauxley random-zero mercury manometer, and at the echocardiographic examination. Elevation of blood pressure was considered present when it exceeded 160 mmhg systolic and/or 95 mmhg diastolic (WHO criteria). Based on these measurements, the populations were divided into three categories: (1) Normotensives: normal blood pressure at the two examinations and no history of antihypertensive medical treatment within the last 6 months. (2) Doubtful hypertensives: subjects with elevated blood pressure on only one occasion with no history of medical antihypertensive treatment. (3) Hypertensives: subjects with elevated blood pressure on both examinations or subjects currently receiving antihypertensive medication for documented hypertension. Statistical analysis Analysis of contingency tables was performed with Chi 2 -test for 2x2 tables with continuity adjustment. In analysis of the relationship between blood pressure and left ventricular mass, Pearsons correlation coefficient, r, and its significance level was calculated. The SAS (SAS Institute, Inc., Cary, NC, U.S.A.) statistical package was used for calculations. Results In Table 1, gender, age and presence of hypertension is shown for 1987 responders, 1987 non-responders and those who had died since the 1982 examination. There were no significant differences between patients who participated and those who did not. The small group of deceased were older, more often male, and more often hypertensive.

3 LVhypertrophy in hypertensives 145 Table 1 Characteristics of the study population based on the examination in 1982 according to their response to the 1987 invitation 1982 population total n = 36O responders n = 2987 (82-8%) Dead since 1982 n= 110 (3-0%) Non-responders n = 511 (14-2%) gender Age in 1982 (mean) 51% 11% -5 years % 31% 53-9 years 48% 11% 0 years Table 2 Final study population of 2 persons subdivided by age, gender and hypertension category. Number of individuals and prevalence of left ventricular hypertrophy is indicated Age (years) s Doubtful hypertension 35 or 45 All n=49 n = 39 18% n = 24 8% n=112 n = 30 23% n = 23 17% n = 29 17% n = 82 20% Table 3 Characteristics of thestudy population of 2 persons Weight (kg) Height (m) BMI (kg.m" BSA (m 2 ) 2 ) Systolic BP (mmhg) Diastolic BP (mmhg) LVM (g) LVM/BSA (g. m" 2 ) n= (59-101) 4 ( ) (20-32) 1-9 ( ) 132 ( ) 83 (69-90) 181 (73-297) 94 (41-146) n = 20 25% n = 23 9% n=17 41% n = 60 23% n = (48-84) 1-62 (1-50-6) 24 (19-29) ( ) 134 ( ) 83 (67-90) 138 (73-235) 83 (40-136) n=12 33% n=18 28% n=13 54% n = 43 37% Doubtful hypertension n = (60-107) 5 ( ) (21-34) 20 (-2-3) 168 ( ) 88 (68-108) 207 (79-352) 108 (41-172) 19% n = 56 39% n=142 25% 68 (51-89) 1-63 (1-53-6) (20-32) ( ( ) 88 (76-110) 166 (64-287) 99 (40-166) n = 29 n = 34 24% n = 50 34% n=l 13 % 84 (66-107) 5 ( ) 27 (21-35) 20 (-2-3) 160 ( ) 101 (83-120) 228 ( ) 114 (54-208) n= (52-99) 1-61 ( ) 27 (20-38) ( ) 160 ( ) 98 (80-116) 159 (-286) 92 (37-166) n = (62-103) 5 (1-1-87) (21-34) 2-0 (-2-2) 151 ( ) 92 (73-114) 207 (85-369) 106 (45-183) All n = (49-89) 1 62 (1-52-4) 25 (20-33) ( ) 148 ( ) 91 (72-112) 153 (-279) 90 (40-154) The composition of the final study population is shown in Tables 2 and 3. (elevated blood pressure on two occasions or on drug therapy for hypertension) was found in 2 subjects. Of these, 130 (51%) were on anti-hypertensive treatment and in this group, normal systolic and diastolic blood pressure on both examinations was recorded in 80% and 74%, respectively. There were 103 subjects in the category 'doubtful hypertension' (elevated blood pressure on only one occasion). blood pressure on both occasions, normal ECG and no history of hypertension were found in 194 subjects. Subjects in the hypertensive groups have a tendency to be more obese than those in the normotensive groups (Table 3). Overall correlation between blood pressure and left ventricular mass is shown graphically in Fig. 1. Left ventricular mass per m 2 body surface area was correlated with diastolic blood pressure with r=0-18 and with systolic blood pressure with r=0-25. In both cases P=00001.

4 146 J. Tingleffet al. Systolic blood pressure (mmhg) 250 The prevalence of left ventricular hypertrophy is shown in Table 2. When all age groups were pooled, left ventricular hypertrophy was significantly more frequent in hypertensives compared to normotensives in both sexes (/ 3 <001). There was a tendency to lower prevalence of left ventricular hypertrophy in normotensives with higher age. For hypertensives, the opposite was seen (higher prevalence of left ventricular hypertrophy in the older age group). Therefore, by subdividing the subjects into sex and age groups, a significant difference between normotensives and hypertensives was found in the -year-old age group (men P<0-02 and women In the small super normal group of patients, there were 45 males and females. For males, LVM. m ~ 2 was mean 86 g. m " 2 and the standard error was 39. For females, LVM. m ~ 2 was 80 g. m ~ 2 and the standard error was 27. These results are very similar to the studies' 7 " 1 from which we chose cut-off values with respect to mean values. The values of standard error observed in our small subgroup was greater. Similar results were obtained when left ventricular mass was analysed as a continuous variable (adjusted for body surface area). Significant differences between participants with no hypertension, doubtful hypertension, and hypertension were only observed in the - year-old age group (/ > =001 for men and / > =002 for women). In the younger age groups, the minimal /"-value was The prevalence of left ventricular hypertrophy was studied in the 2 persons categorised as hypertensives and subdivided according to treatment. Among 1 subjects with untreated hypertension, 36% had left ventricular hypertrophy. Among 45 subjects receiving antihypertensive medication but categorised as hypertensives on blood pressure criteria, 40% had left ventricular hypertrophy. Among 84 persons with normal

5 LVhypertrophy in hypertensives a ho Figure 1 (b) Systolic blood pressure (mmhg) Figure 1 The relationship between blood pressure (x-axis) and left ventricular mass per body surface area (g. m ~ 2 ) (y-axis), in systolic (a) and (b) diastolic pressure (mmhg). blood pressure but receiving antihypertensive medication for documented hypertension, 30% had left ventricular hypertrophy. These figures do not differ significantly and in this study, a relationship between antihypertensive medication and prevalence of left ventricular hypertrophy could not be seen. Most hypertensives were treated with diuretics, some with beta-blockers, and very few with calcium antagonists and angjotensin converting enzyme inhibitors. Discussion The population studied was selected in 1982 and underwent an initial examination in that year and a re-examination in Of the initial study group, 110 had died before undergoing re-examination, but we do not believe this introduces bias. In the present study, the sample size was influenced but not the composition of the unselected population at the time of the reexamination. The fact that those who had died in the intermediate period more often had hypertension introduces a clear bias when results in different age groups are compared. With respect to a cross-sectional study as that performed in 1987, the bias introduced is no greater than if the slightly smaller sample were selected from the whole population. The difference between this study and a study initiated in 1987 is that the bias of comparison of age groups is documented. At the new examination, 85% accepted the invitation and the prevalence of hypertension did not differ between participants and nonparticipants. For these reasons we consider the sample population as representative as possible. Although electrocardiographic detection of left ventricular hypertrophy has been used for epidemiological studies, echocardiographic evidence of left ventricular hypertrophy has proven to be a much more sensitive and specific method to measure left ventricular mass 112 '.

6 148 J. Tingleffet al. Table 4 Mean, standard deviation (SD), median 5th percentile (5%) and 95th percentile (95%) of left ventricular mass as g. m~ 2 surface area subdivided by gender, age and hypertension category. =possible hypertension Gender Age (years) Category Mean SD Median 5% 95% Epidemiological studies of left ventricular mass should, therefore, mainly be based on echocardiographic findings. In addition to the relationship of left ventricular mass to hypertension, there are important links between left ventricular mass and body size measurements such as weight, height and body surface area' 131. In our study, we indexed left ventricular mass to body surface area. This is a well accepted method used in others studies' 5 ' 61. The prevalence of echocardiographic left ventricular hypertrophy is mainly based on studies in the hypertensive population with reference to normotensive subjects. These studies suggest that the prevalence of left ventricular hypertrophy is 23% to 48% in hypertensives' 5 ' 14 ' 151, with a higher prevalence in elderly patients with well controlled hypertension' 16 '. The overall prevalence in the general population with and without hypertension has been suggested to be 16% and 19% for men and women, respectively In our study, we found the prevalence of left ventricular hypertrophy to be /20% (men/women) in normotensives and 25%/% in the hypertensive population. The difference between our results and those previously reported could be due to selection criteria. In some studies, the hypertensive population consisted of highly selected patients attending a particular clinic having mild uncomplicated hypertension 151, or 140 mmhg systolic and/or 90 mmhg diastolic blood pressure was used as a cut off value 1 ' 3 ' 14 '. We reported the prevalence of left ventricular hypertrophy in an unselected hypertensive population, and used the WHO recommendation for definition of hypertension. We found a relatively high prevalence of left ventricular hypertrophy in normotensives, particularly in the younger age groups. In some respects, we believe this reflects the value in a non-selected normotensive population. Our mean left ventricular mass index for normotensives was 94 g. m~ 2 for men and 83 g. m~ 2 for women (Table 3), which is in accordance with the findings of others' 6 ' 7 "'. Therefore, the discrepancy with other studies in frequency of left ventricular hypertrophy in the normal population was unlikely to be due to measurement problems. The frequency of left ventricular hypertrophy in a subgroup is sensitive to the cut-off value for normal mass. The cut-off values used in this investigation were taken from the Framingham study' 71 and from a study by Devereaux et a/.'" 1. We tested whether these values were appropriate in our population. Using a similar normal population as described in the Framingham study 171, we found 89 super normal individuals. Mean LVM. m~ 2 was similar in our normal population and that of Framingham/Devereaux, but the standard deviation was greater in our population. However, our population of super-normals was small and therefore, we decided to use the previously published values. The principal results of this study are not sensitive to the chosen cut-off values, as similar results were obtained when left ventricular mass was used as a continuous variable. Similar to others studies, we found a weak overall correlation between blood pressure and left ventricular hypertrophy 121. The correlation was highly significant because of the many data available, but the r-values of approximately 0-2 indicate that only about 5% of the variation in left ventricular mass can be accounted for by linear correlation with blood pressure. The correlation to blood pressure may be stronger when 24 h ambulatory blood pressure monitoring is used" 81. A significant difference in left ventricular hypertrophy between normotensives and hypertensives was

7 LV hypertrophy in hypertensives 149 found only in the -year-age group. It is interesting to speculate whether this reflects the notion that hypertension needs to be present for a long time to induce left ventricular hypertrophy. However, as illustrated by the analysis of participants who had died since 1982, comparison between the age groups is biased. Left ventricular hypertrophy in essential hypertension can be reversed by medical treatment. Centrally acting alpha-adrenergic blockers, angiotensin converting enzyme inhibitors and calcium channel antagonists induce an effective reduction in left ventricular mass, whereas the vasodilators, diuretics and beta-adrenergic blockers do not have this effect' 19 ' 20 '. Although there was a tendency toward a lower prevalence of left ventricular hypertrophy between successfully and unsuccessfully medically treated patients, this difference did not become significant. In our hypertensive population, diuretic and beta-adrenergic drugs were used almost universally as antihypertensive treatment, and this may explain the lack of difference in prevalence of left ventricular hypertrophy between treated and non-treated subjects. In conclusion, we found that in younger age groups there is no difference in the prevalence of left ventricular hypertrophy between normotensives and hypertensives. With increasing age there is a moderate but significant relation to hypertension. References [1] Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75: [2] Savage DD, Garrison RJ, Kannel WB et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987, 75: i 33. [3] Savage DD, Drayer JI, Henry WL et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979; 59: [4] Casale PN, Devereux RB, Milner M et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: [5] Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: [6] Hammond 1W, Devereux RB, Alderman MH et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed persons with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: [7] Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: [8] Laufer E, Jennings GL, Korner PI, Dewar E. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. 1989; 13: [9] Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass: Anatomic validation of the method. Circulation 1977; : [10] Devereux RB, Alonson DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: [11] Devereux RB, Lutas EM, Casale PN et al. Standardization of M-mode echocardiographic left ventricular. J Am Coll Cardiol 1984; 4: [12] Reickek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomical, echocardiographic, and electrocardiographic findings. Circulation 1981; 63: [13] Devereux RB. Left ventricular mass in children and adolescents J Am Coll Cardiol 1988; 12: [14] Devereux RB, Savage DD, Drayer JI, Laragh JH. Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. 1982; 4: [15] Devereux RB, Pickering TG, Harshfield GA et al Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983, 68: [16] Jones E, Morgan TO, Califiore P, Johns J. Prevalence of left ventricular hypertrophy in elderly patients with well controlled hypertension. Clin Exp Pharmacol Physiol 1990; 17: [17] Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC,Castelli WP. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. Ann Int Med 1988; 108:7-13. [18] Verdecchia P, Schillaci G, Guerrieri M et al. Orcadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: [19] Liebsen PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens 1990; 3: [20] Ram CV. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications. J Hypertens 1987; 7 (Suppl): s98-9.

Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?

Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass? Journal of Human Hypertension (1999) 13, 505 509 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Echocardiographic definition of left ventricular

More information

Left Ventricular Hypertrophy Evaluation in Obese Hypertensive Patients. Effect of Left Ventricular Mass Index Criteria

Left Ventricular Hypertrophy Evaluation in Obese Hypertensive Patients. Effect of Left Ventricular Mass Index Criteria Original Article Left Ventricular Hypertrophy Evaluation in Obese Hypertensive Patients. Effect of Left Ventricular Mass Index Criteria Eduardo Cantoni Rosa, Valdir Ambrósio Moysés, Ricardo Cintra Sesso,

More information

Association of body surface area and body composition with heart structural characteristics of female swimmers

Association of body surface area and body composition with heart structural characteristics of female swimmers Original Research Association of body surface area and body composition with heart structural characteristics of female swimmers BAHAREH SHEIKHSARAF 1, NIKBAKHT HOJAT ALLAH 2, and AZARBAYJANI MOHAMMAD

More information

Interventricular Septum Thickness Predicts Future Systolic Hypertension in Young Healthy Pilots

Interventricular Septum Thickness Predicts Future Systolic Hypertension in Young Healthy Pilots 15 Original Article Hypertens Res Vol.31 (2008) No.1 p.15-20 Interventricular Septum Thickness Predicts Future Systolic Hypertension in Young Healthy Pilots Chagai GROSSMAN 1), Alon GROSSMAN 2), Nira KOREN-MORAG

More information

Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?

Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? (24) 18, S23 S28 & 24 Nature Publishing Group All rights reserved 95-92/4 $3. www.nature.com/jhh ORIGINAL ARTICLE Does the reduction in systolic blood pressure alone explain the regression of left ventricular

More information

LEFT VENTRICULAR HYPERTROPHY AND CLINICAL OUTCOME IN CAPD PATIENTS

LEFT VENTRICULAR HYPERTROPHY AND CLINICAL OUTCOME IN CAPD PATIENTS Peritoneal Dialysis International, Vol. 20, pp. 461 466 Printed in Canada. All rights reserved. 0896-8608/00 $3.00 +.00 Copyright 2000 International Society for Peritoneal Dialysis LEFT VENTRICULAR HYPERTROPHY

More information

Kathmandu University Medical Journal (2010), Vol. 8, No. 2, Issue 30,

Kathmandu University Medical Journal (2010), Vol. 8, No. 2, Issue 30, Kathmandu University Medical Journal (2010), Vol. 8, No. 2, Issue 30, 173-178 Original Research Article Effect of haemodynamic and metabolic predictors on echocardiographic left ventricular mass in non-diabetic

More information

The Relationship Between Measures Of Obesity And Echocardiographic Determinants Of Left Ventricular Hypertrophy In Nigerian Adults

The Relationship Between Measures Of Obesity And Echocardiographic Determinants Of Left Ventricular Hypertrophy In Nigerian Adults ISPUB.COM The Internet Journal of Cardiology Volume 9 Number The Relationship Between Measures Of Obesity And Echocardiographic Determinants Of Left Ventricular O IC, A OS, O OJ, U DI Citation O IC, A

More information

Should all patients with hypertension have echocardiography?

Should all patients with hypertension have echocardiography? (2000) 14, 417 421 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh REVIEW ARTICLE Should all patients with hypertension have echocardiography? G de Simone 1,2,

More information

Angiotensin II Receptor Blocker Telmisartan: Effect on Blood Pressure Profile and Left Ventricular Hypertrophy in Patients with Arterial Hypertension*

Angiotensin II Receptor Blocker Telmisartan: Effect on Blood Pressure Profile and Left Ventricular Hypertrophy in Patients with Arterial Hypertension* The Journal of International Medical Research 2005; 33 (Suppl 1): 21A 29A Angiotensin II Receptor Blocker Telmisartan: Effect on Blood Pressure Profile and Left Ventricular Hypertrophy in Patients with

More information

Preventing the cardiovascular complications of hypertension

Preventing the cardiovascular complications of hypertension European Heart Journal Supplements (2004) 6 (Supplement H), H37 H42 Preventing the cardiovascular complications of hypertension Peter Trenkwalder* Department of Internal Medicine, Starnberg Hospital, Ludwig

More information

The Associations of Body Size and Body Composition With Left Ventricular Mass: Impacts for Indexation in Adults

The Associations of Body Size and Body Composition With Left Ventricular Mass: Impacts for Indexation in Adults 451 LEFT VENTRICULAR HYPERTROPHY The Associations of Body Size and Body Composition With Left Ventricular Mass: Impacts for Indexation in Adults HANS-WERNER HENSE, MD, BIRGIT GNEITING, MSC,* MICHAEL MUSCHOLL,

More information

Ref 1. Ref 2. Ref 3. Ref 4. See graph

Ref 1. Ref 2. Ref 3. Ref 4. See graph Ref 1 Ref 2 Ref 3 1. Ages 6-23 y/o 2. Significant LVM differences by gender 3. For males 95 th percentiles: a. LVM/BSA = 103 b. LVM/height = 100 4. For females 95 th percentiles: a. LVM/BSA = 84 b. LVM/height

More information

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice (2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and

More information

Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors

Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors The Journal of International Medical Research 2011; 39: 64 70 Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors H MASUGATA,

More information

Prognostic significance of blood pressure measured on rising

Prognostic significance of blood pressure measured on rising (2001) 15, 413 417 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured on rising P Gosse, C Cipriano,

More information

Management of Stage B Heart Failure

Management of Stage B Heart Failure KSC 2017 Management of Stage B Heart Failure Byung Su Yoo, MD., PhD. Division of Cardiology, Wonju College of Medicine, Yonsei University, South Korea Focused on Symptom ASLVSD, ASLVDD LVH HF progression

More information

Abstract. Introduction. Al- Kindy Col Med J 2007; Vol.4 (1)

Abstract. Introduction. Al- Kindy Col Med J 2007; Vol.4 (1) Left Ventricular Hypertrophy in Diabetic Patients and Its Relation to Other Diabetic Complications *Hilal B. shawki FRCP, FACC*, Jawad A. kadhim MD, FICMS **, Adil S. Ghafour FRCP,FACC ***, Amal Al Marayati

More information

Updates on Cardiac Enlargement in US Firefighters. Maria Korre, MSc, ScD

Updates on Cardiac Enlargement in US Firefighters. Maria Korre, MSc, ScD Updates on Cardiac Enlargement in US Firefighters Maria Korre, MSc, ScD Research Associate-Instructor Environmental & Occupational Medicine & Epidemiology Program Department of Environmental Health Harvard

More information

Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension

Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension JACC Vol. 31, No. 2 February 1998:383 90 383 Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension PAOLO VERDECCHIA, MD, GIUSEPPE

More information

Reversibility of Cardiac Abnormalities in Morbidly Obese Adolescents

Reversibility of Cardiac Abnormalities in Morbidly Obese Adolescents Journal of the American College of Cardiology Vol. 51, No. 14, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.12.029

More information

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD Board Review Course 2017 43 year old health assistant Severe resistant HTN LT BSA 2 Height 64 1 Here is the M mode echocardiogram

More information

Abnormal ECG patterns and significance in a group of mountaineers

Abnormal ECG patterns and significance in a group of mountaineers Original Article Abnormal ECG patterns and significance in a group of mountaineers Wg Cdr V Vasdev*, Wg Cdr DS Chadha +, Gp Capt P Kharbanda #, Lt Col SK Datta**, Air Cmde RK Ganjoo AVSM VSM ++ ABSTRACT

More information

A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Left Ventricular Hypertrophy in Korean Patients

A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Left Ventricular Hypertrophy in Korean Patients Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Left Ventricular Hypertrophy in Korean

More information

Overview of the outcome trials in older patients with isolated systolic hypertension

Overview of the outcome trials in older patients with isolated systolic hypertension Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated

More information

Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease

Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease ARLENE B. CHAPMAN,* ANN M. JOHNSON, SUSAN RAINGUET,* KENNETH HOSSACK,* PATRICIA GABOW,* and ROBERT W. SCHRIERt *De,,j,er Health

More information

HOW CONSISTENT ARE THE BLOOD PRESSURE AND PULSE RATE MEASUREMENTS OF THE ELECTRONIC BP APPARATUS AND THE MANUAL SPHYGMOMANOMETER

HOW CONSISTENT ARE THE BLOOD PRESSURE AND PULSE RATE MEASUREMENTS OF THE ELECTRONIC BP APPARATUS AND THE MANUAL SPHYGMOMANOMETER HOW CONSISTENT ARE THE BLOOD PRESSURE AND PULSE RATE MEASUREMENTS OF THE ELECTRONIC BP APPARATUS AND THE MANUAL SPHYGMOMANOMETER Naser KA. Teaching Hospital Peradeniya, Peradeniya, Sri Lanka Zawahir S

More information

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.

More information

Cedars Sinai Diabetes. Michael A. Weber

Cedars Sinai Diabetes. Michael A. Weber Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor

More information

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension (2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with

More information

Correlation between the morning hypertension on ambulatory blood pressure monitoring and the left ventricular mass in children

Correlation between the morning hypertension on ambulatory blood pressure monitoring and the left ventricular mass in children Original article Korean J Pediatr 2014;57(9):403-409 pissn 1738-1061 eissn 2092-7258 Korean J Pediatr Correlation between the morning hypertension on ambulatory blood pressure monitoring and the left ventricular

More information

Morning Hypertension: A Pitfall of Current Hypertensive Management

Morning Hypertension: A Pitfall of Current Hypertensive Management Review Article Hypertension: A Pitfall of Current Hypertensive Management JMAJ 48(5): 234 240, 2005 Kazuomi Kario* 1 Abstract has recently attracted more attention because of the close relation between

More information

Left Ventricular Mass in Patients with Heart Failure

Left Ventricular Mass in Patients with Heart Failure Original Article Marcello Ricardo Paulista Markus, Humberto Felício Gonçalves de Freitas, Paulo Roberto Chizzola, Gisela Tunes da Silva, Antonio Carlos Pedroso de Lima, Alfredo José Mansur São Paulo, SP

More information

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,

More information

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection

More information

The role of physical activity in the prevention and management of hypertension and obesity

The role of physical activity in the prevention and management of hypertension and obesity The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity

More information

Unexplained Pulmonary Hypertension in Elderly Patients* Brian P. Shapiro, MD; Michael D. McGoon, MD, FCCP; and Margaret M.

Unexplained Pulmonary Hypertension in Elderly Patients* Brian P. Shapiro, MD; Michael D. McGoon, MD, FCCP; and Margaret M. CHEST Unexplained Pulmonary Hypertension in Elderly Patients* Brian P. Shapiro, MD; Michael D. McGoon, MD, FCCP; and Margaret M. Redfield, MD Original Research PULMONARY HYPERTENSION Background: Idiopathic

More information

LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM

LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM Riccardo Marsili, Pietro Iacconi, Massimo Chiarugi, Giampaolo Bernini*, Alessandra Bacca*, Paolo Miccoli Department

More information

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Martin G. Keane, MD, FASE Temple University School of Medicine

Martin G. Keane, MD, FASE Temple University School of Medicine Martin G. Keane, MD, FASE Temple University School of Medicine Measurement of end-diastolic LV internal diameter (LVIDd) made by properly-oriented M-Mode techniques in the Parasternal Long Axis View (PLAX):

More information

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease (2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk

More information

Comparison of left ventricular mass in normotensive type 2 diabetes mellitus patients with that in the nondiabetic population

Comparison of left ventricular mass in normotensive type 2 diabetes mellitus patients with that in the nondiabetic population jcdr_56_10 JCDR Original Article Comparison of left ventricular mass in normotensive type 2 diabetes mellitus patients with that in the nondiabetic population Sukamal Santra, Asish Kumar Basu 1, Pradip

More information

Metoprolol Succinate SelokenZOC

Metoprolol Succinate SelokenZOC Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic

More information

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,

More information

Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine

Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine 831 Original Article Hypertens Res Vol.3 (27) No.9 p.831-837 Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine

More information

Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary

Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary 1 IMAGES IN CARDIOVASCULAR ULTRASOUND 2 3 4 Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary Artery 5 6 7 Byung Gyu Kim, MD 1, Sung Woo Cho, MD 1, Dae Hyun Hwang, MD 2 and Jong

More information

Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis

Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis ORIGINAL ARTICLE Cardiology Journal 2010, Vol. 17, No. X, pp. 1 XX Copyright 2010 Via Medica ISSN 1897 5593 Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients:

More information

Normal systolic blood pressure and risk of heart failureinusmalephysicians

Normal systolic blood pressure and risk of heart failureinusmalephysicians European Journal of Heart Failure (2009) 11, 1129 1134 doi:10.1093/eurjhf/hfp141 Normal systolic blood pressure and risk of heart failureinusmalephysicians Kathryn A. Britton 1,2 *, J. Michael Gaziano

More information

Left Ventricular Geometry and All-cause Mortality in Advanced Age

Left Ventricular Geometry and All-cause Mortality in Advanced Age Heart, Lung and Circulation (2015) 24, 32 39 1443-9506/04/$36.00 http://dx.doi.org/10.1016/j.hlc.2014.06.017 ORIGINAL ARTICLE Left Ventricular Geometry and All-cause Mortality in Advanced Age Ruth O. Teh,

More information

connections among resting heart rate, ambulatory blood pressure and left ventricular hypertrophy

connections among resting heart rate, ambulatory blood pressure and left ventricular hypertrophy Int J Clin Exp Med 2016;9(2):4467-4472 www.ijcem.com /ISSN:1940-5901/IJCEM0010035 Original Article The connections among resting heart rate, ambulatory blood pressure and left ventricular hypertrophy in

More information

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario M Paul Anand Consultant Physician, Lady Ratan Tata Medical Centre, M. Karve Road, Cooperage, Mumbai Executive Editor, API Textbook of Medicine Introduction

More information

ORIGINAL ARTICLE. Introduction. Materials and methods

ORIGINAL ARTICLE. Introduction. Materials and methods Journal of Human Hypertension (1999) 13, 111 116 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Value of ambulatory intra-arterial blood

More information

ORIGINAL INVESTIGATION. Left Atrium Size and the Risk of Cardiovascular Death in Middle-aged Men. evaluating cardiovascular

ORIGINAL INVESTIGATION. Left Atrium Size and the Risk of Cardiovascular Death in Middle-aged Men. evaluating cardiovascular ORIGINAL INVESTIGATION Left Atrium Size and the Risk of Cardiovascular Death in Middle-aged Men Jari A. Laukkanen, MD; Sudhir Kurl, MD; Jaakko Eränen, MD; Matti Huttunen, MD; Jukka T. Salonen, MD, hd,

More information

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey Interatrial Block and P-Terminal Force: A Reflection of Mitral Stenosis Severity on Electrocardiography Murat Yuce 1, Vedat Davutoglu 1, Cayan Akkoyun 1, Nese Kizilkan 2, Suleyman Ercan 1, Murat Akcay

More information

Talib Y. Ali, MD, MPH Lt Col, USAF, MC, FS. USAF School of Aerospace Medicine WPAFB, OH RAM 2013

Talib Y. Ali, MD, MPH Lt Col, USAF, MC, FS. USAF School of Aerospace Medicine WPAFB, OH RAM 2013 Association of New Left Anterior Fascicular Block with Structural Heart Disease in U.S. Air Force Military Aircrew Talib Y. Ali, MD, MPH Lt Col, USAF, MC, FS USAF School of Aerospace Medicine WPAFB, OH

More information

AFRICA CARDIOVASCULAR JOURNAL OF AFRICA Vol 23, No 3, April 2012

AFRICA CARDIOVASCULAR JOURNAL OF AFRICA Vol 23, No 3, April 2012 AFRICA CARDIOVASCULAR JOURNAL OF AFRICA Vol 23, No 3, April 2012 147 Prevalence of residual left ventricular structural changes after one year of antihypertensive treatment in patients of African descent:

More information

Ejection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction

Ejection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction Keith Miller MD Diastolic Heart Failure Risk Factors Common Risk Factors Aging Female gender Obesity Hypertension Diabetes mellitus

More information

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation

More information

Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs

Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs (2002) 16 (Suppl 2), S24 S28 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh compared with other antihypertensive drugs University Clinic Bonn, Department of Internal

More information

In patients with aortic dissection, expansion of the false

In patients with aortic dissection, expansion of the false Left Ventricular Diastolic Dysfunction in Chronic Aortic Dissection Yasushige Shingu, MD, Norihiko Shiiya, MD, PhD, Taisei Mikami, MD, PhD, Kenji Matsuzaki, MD, Takashi Kunihara, MD, PhD, and Yoshiro Matsui,

More information

J Cardiovasc Med 2013, 14: a The Israeli Air Force Aero Medical Center, Tel Hashomer, b Department of

J Cardiovasc Med 2013, 14: a The Israeli Air Force Aero Medical Center, Tel Hashomer, b Department of CE: amrta; JCM/21761; Total nos of Pages: 6; JCM 21761 Original article M-mode echocardiographic values in a cohort of young healthy individuals Alon Grossman a,b, Michal Benderly c,d, Alex Prokupetz a,

More information

Increased heart rate as a risk factor for cardiovascular disease

Increased heart rate as a risk factor for cardiovascular disease European Heart Journal Supplements (23) 5 (Supplement G), G3 G9 Increased heart rate as a risk factor for cardiovascular disease Department of Cardiology, VA Medical Center, West Los Angeles, and Department

More information

Left Ventricular Hypertrophy the Problem and Possible Solutions

Left Ventricular Hypertrophy the Problem and Possible Solutions The Journal of International Medical Research 2005; 33 (Suppl 1): 3A 11A Left Ventricular Hypertrophy the Problem and Possible Solutions P GOSSE Cardiology Service Arterial Hypertension, Hospital Saint-André,

More information

Regression of left ventricular hypertrophy: lessons from clinical trials

Regression of left ventricular hypertrophy: lessons from clinical trials Page 1 of 8 Systematic s Regression of left ventricular hypertrophy: lessons from clinical trials P Pokharel 1, JN Bella 1,2 * Abstract Introduction Hypertension is an epidemic that affects more than 1

More information

Advances in Peritoneal Dialysis, Vol. 29, 2013

Advances in Peritoneal Dialysis, Vol. 29, 2013 Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate

More information

Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo?

Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo? Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo? Prof. Massimo Salvetti Clinica Medica University of Brescia Percieved risk Actual risk Sehestedt et al,

More information

Hypertension is a common disease in our

Hypertension is a common disease in our AJH 2000;13:1161 1167 Effect of Indomethacin on Blood Pressure in Elderly People With Essential Hypertension Well Controlled on or Trefor O. Morgan, Adrianne Anderson, and Denise Bertram Arthritis and

More information

1 Department of Medical Physics, Royal Infirmary of Edinburgh, 2 Department of. Received 11 June 2004 Accepted 7 September 2004

1 Department of Medical Physics, Royal Infirmary of Edinburgh, 2 Department of. Received 11 June 2004 Accepted 7 September 2004 Devices and technology 1 Do SpaceLabs ambulatory non-invasive blood pressure recorders measure blood pressure consistently over several years use? John N. Amoore 1, David Dewar 2, Kathleen Gough 3 and

More information

Ambulatory Blood Pressure Measurement. Objectives of the Presentation. Methods of Measuring BP: Pros and Cons

Ambulatory Blood Pressure Measurement. Objectives of the Presentation. Methods of Measuring BP: Pros and Cons Ambulatory Blood Pressure Measurement William B. White, MD Professor of Medicine and Chief, Hypertension and Clinical Pharmacology Calhoun Cardiology Center University of Connecticut School of Medicine

More information

There is convincing evidence in clinical studies

There is convincing evidence in clinical studies AJH 1998;11:1413 1417 Reliability of Reporting Self-Measured Blood Pressure Values by Hypertensive Patients Thomas Mengden, Rosa Maria Hernandez Medina, Belen Beltran, Elena Alvarez, Karin Kraft, and Hans

More information

Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population

Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population Park et al. BMC Medical Genetics (2015) 16:13 DOI 10.1186/s12881-015-0158-1 RESEARCH ARTICLE Open Access Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy

More information

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence JNC 7 Is Nice But What s Up With JNC 8? 37 th Annual CAPA Conference October 4 th 2013 Ignacio de Artola, Jr. M.D. Assistant Professor of Clinical Family Medicine Medical Director, Primary Care Physician

More information

Ambulatory blood pressure, target organ damage and aortic root size in nevertreated essential hypertensive patients

Ambulatory blood pressure, target organ damage and aortic root size in nevertreated essential hypertensive patients (2007) 21, 531 538 & 2007 Nature Publishing Group All rights reserved 0950-9240/07 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Ambulatory blood pressure, target organ damage and aortic root size in nevertreated

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 2002 by the Massachusetts Medical Society VOLUME 347 A UGUST 1, 2002 NUMBER 5 OBESITY AND THE RISK OF HEART FAILURE SATISH KENCHAIAH, M.D., JANE C. EVANS,

More information

The Road to Renin System Optimization: Renin Inhibitor

The Road to Renin System Optimization: Renin Inhibitor The Road to Renin System Optimization: Renin Inhibitor A New Perspective on the Renin-Angiotensin System (RAS) Yong-Jin Kim, MD Seoul National University Hospital Human and Economic Costs of Hypertension

More information

Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients

Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients Neth Heart J (2014) 22:234 239 DOI 10.1007/s12471-014-0543-y ORIGINAL ARTICLE Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients L. Ringoir & J. W. Widdershoven

More information

Introduction. Materials and Methods. Andrea C. Vollmar, DVM

Introduction. Materials and Methods. Andrea C. Vollmar, DVM Use of Echocardiography in the Diagnosis of Dilated Cardiomyopathy in Irish Wolfhounds The purpose of this study was to compare the echocardiographic features of Irish wolfhounds with clinically inapparent

More information

Blood Pressure Goal in Elderly Hypertensive Patients with Diabetes Mellitus: A Subanalysis of the CASE-J Trial

Blood Pressure Goal in Elderly Hypertensive Patients with Diabetes Mellitus: A Subanalysis of the CASE-J Trial Blood Pressure Goal in Elderly Hypertensive Patients with Diabetes Mellitus: A Subanalysis of the CASE-J Trial Kenji Ueshima 1, Shinji Yasuno 1, Sachiko Tanaka 1, Akira Fujimoto 1, Toshio Ogihara 2, Takao

More information

Chamber Quantitation Guidelines: What is New?

Chamber Quantitation Guidelines: What is New? Chamber Quantitation Guidelines: What is New? Roberto M Lang, MD J AM Soc Echocardiogr 2005; 18:1440-1463 1 Approximately 10,000 citations iase in itune Cardiac Chamber Quantification: What is New? Database

More information

Effects of Nasal Continuous Positive Airway Pressure on Left Ventricular Concentric Hypertrophy in Obstructive Sleep Apnea Syndrome

Effects of Nasal Continuous Positive Airway Pressure on Left Ventricular Concentric Hypertrophy in Obstructive Sleep Apnea Syndrome ORIGINAL ARTICLE Effects of Nasal Continuous Positive Airway Pressure on Left Ventricular Concentric Hypertrophy in Obstructive Sleep Apnea Syndrome Seiji Koga, Satoshi Ikeda, Tomoo Nakata, Tomohiko Yasunaga

More information

Potential Conflicts of Interest. Speaker s fee / Consultancy:

Potential Conflicts of Interest. Speaker s fee / Consultancy: Potential Conflicts of Interest ESC Stockholm 2010 Bernard Iung, MD Speaker s fee / Consultancy: St. Jude Medical Edwards Lifesciences Sanofi-Aventis Servier Boehringer Ingelheim Acute Decompensation of

More information

Echocardiographic study of left ventricular diastolic dysfunction in normotensive asymptomatic type II diabetes mellitus

Echocardiographic study of left ventricular diastolic dysfunction in normotensive asymptomatic type II diabetes mellitus IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 7 Ver. VI (July. 2015), PP 39-43 www.iosrjournals.org Echocardiographic study of left ventricular

More information

Objectives. Describe results and implications of recent landmark hypertension trials

Objectives. Describe results and implications of recent landmark hypertension trials Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships

More information

MAYON VOLCANO: FAST FACTS

MAYON VOLCANO: FAST FACTS MAYON VOLCANO: FAST FACTS Type of Volcano: Stratovolcano Elevation: 2.46 km Base Diameter: 20 km Base Circumference: 62.8 km Area: 314.1 km 2 Reference: http://www.phivolcs.dost.gov.ph/html/update_vmepd/volcano/volcanolist/mayon.htm

More information

By Prof. Khaled El-Rabat

By Prof. Khaled El-Rabat What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating

More information

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi Is Choice of Antihypertensive Agent Important in Improving Cardiovascular Outcomes in High-Risk Hypertensive Patients? Commentary on Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators.

More information

CHRONIC essential hypertension is a major risk

CHRONIC essential hypertension is a major risk 1462 THE NEW ENGLAND JOURNAL OF MEDICINE Nov. 30, 1995 EFFECTS OF REGULAR EXERCISE ON BLOOD PRESSURE AND LEFT VENTRICULAR HYPERTROPHY IN AFRICAN-AMERICAN MEN WITH SEVERE HYPERTENSION PETER F. KOKKINOS,

More information

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

The new Guidelines: Focus on Chronic Heart Failure

The new Guidelines: Focus on Chronic Heart Failure The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal

More information

Electrocardiogram Sensitivity in Left Ventricular Hypertrophy According to Gender and Cardiac Mass

Electrocardiogram Sensitivity in Left Ventricular Hypertrophy According to Gender and Cardiac Mass Electrocardiogram Sensitivity in Left Ventricular Hypertrophy According to Gender and Cardiac Mass Ana P. Colossimo, Francisco de Assis Costa, Andrés R. P. Riera, Maria T. N. Bombig, Valter C. Lima, Francisco

More information

OPEN EVALUATION OF LABETALOL IN THE TREATMENT OF ANGINA PECTORIS OCCURRING IN HYPERTENSIVE PATIENTS

OPEN EVALUATION OF LABETALOL IN THE TREATMENT OF ANGINA PECTORIS OCCURRING IN HYPERTENSIVE PATIENTS Br. J. clin. Pharmac. (1979), 8, 25S-29S OPN VALUATION OF LABTALOL IN TH TRATMNT OF ANGINA PTORIS ORRING IN HYPRTIV PATINTS.M.M. BSTRMAN & M. SPNR ardiological Department, St Mary's Hospital, Norfolk Place,

More information

Jong-Won Ha*, Jeong-Ah Ahn, Jae-Yun Moon, Hye-Sun Suh, Seok-Min Kang, Se-Joong Rim, Yangsoo Jang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho

Jong-Won Ha*, Jeong-Ah Ahn, Jae-Yun Moon, Hye-Sun Suh, Seok-Min Kang, Se-Joong Rim, Yangsoo Jang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho Eur J Echocardiography (2006) 7, 16e21 CLINICAL/ORIGINAL PAPERS Triphasic mitral inflow velocity with mid-diastolic flow: The presence of mid-diastolic mitral annular velocity indicates advanced diastolic

More information

Diagnostic approach to heart disease

Diagnostic approach to heart disease Diagnostic approach to heart disease Initial work up History Physical exam Chest radiographs ECG Special studies Echocardiography Cardiac catheterization Echocardiography principles Technique of producing

More information

Clinical cases with Coversyl 10 mg

Clinical cases with Coversyl 10 mg Clinical cases Coversyl 10 mg For upgraded benefits in hypertension A Editorial This brochure, Clinical cases Coversyl 10 mg for upgraded benefits in hypertension, illustrates a variety of hypertensive

More information

PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN

PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN DR.AZAD ABDUL JABAR HALEEM AL-MEZORI- Dohuk Medical school/ University of Duhok-Kurdistan- Iraq Prof. Dr. AbbasAl-Rabaty-HawlerMedical

More information

Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients

Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients (2009) 23, 743 750 & 2009 Macmillan Publishers Limited All rights reserved 0950-9240/09 $32.00 www.nature.com/jhh ORIGINAL ARTICLE Blood pressure levels, left ventricular mass and function are correlated

More information

The Global SYMPLICITY Registry: Safety and Effectiveness of Renal Artery Denervation In Real World Patients With Uncontrolled Hypertension

The Global SYMPLICITY Registry: Safety and Effectiveness of Renal Artery Denervation In Real World Patients With Uncontrolled Hypertension The Global SYMPLICITY Registry: Safety and Effectiveness of Renal Artery Denervation In Real World Patients With Uncontrolled Hypertension Michael Böhm, MD on behalf of the GSR Investigators March 30,

More information

LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?

LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR? LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR? Juan Cinca Department and Chair of Cardiology Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona

More information